The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025)
Advanced Science · 2025-10 · 12 (37)
DOI: 10.1002/advs.71801 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.10.2025. Verfasst von Shuai Liu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liu, S., Kang, S., Lin, N., Zhang, W., Wang, S., Ren, Y., Ding, X., Yu, J., & Xie, R. (2025). The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025). Advanced Science, 12(37). https://doi.org/10.1002/advs.71801
Vancouver
Liu S, Kang S, Lin N, Zhang W, Wang S, Ren Y, et al. The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025). Advanced Science. 2025;12(37). doi:10.1002/advs.71801
BibTeX
@article{Liu2025,
author = {Liu, Shuai and Kang, Shaobo and Lin, Na and Zhang, Wenqi and Wang, Shiwen and Ren, Yuqing and Ding, Xiaofan and Yu, Jianxiu and Xie, Ruiyu},
title = {The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma (Adv. Sci. 37/2025)},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {37},
doi = {10.1002/advs.71801}
}
EUVIMED